Month: June 2023

Clinical Trials | ProEd Regulatory | Uncategorized

Quick Snips: CRISPR
ByJackie Orabone June 22, 2023February 27, 2024

CRISPR is a powerful gene-editing tool that enables targeted therapeutic gene editing, with clinical applications for improving treatment of inherited and/or rare genetic diseases, viral infections, and arresting the progression of cancer. CRISPR gene-editing technology has the potential to revolutionize the treatment of rare genetic disorders, with the first product poised for FDA approval in…

Read More Quick Snips: CRISPR
Clinical Trials | Publications

Neurology Takes a Page Out of the Oncology Playbook of FDA Accelerated Approvals
ByMuzamil Saleem June 16, 2023April 24, 2025

The field of neurology is experiencing a significant upswing in innovative therapeutic development, propelled by advances in genetics, neuroimaging techniques, and biomarker research. However, neurological diseases are inherently difficult to treat, and there remains an urgent need to rapidly translate these advances into more effective treatments. It is timely then, that several recent drug approvals…

Read More Neurology Takes a Page Out of the Oncology Playbook of FDA Accelerated Approvals